Nfocus Neuromedical, Inc. Luna™ Aneurysm Embolization System Receives CE Mark
Significant milestone for innovative device designed to treat brain aneurysms
Nfocus Neuromedical Luna™ Aneurysm Embolization System Demonstrates Clinical Utility in Brain Aneurysm
Preliminary Clinical Data Presented Today at European Neuroradiology Meeting
Nfocus Neuromedical Appoints Eric Milledge Chief Executive Officer
Johnson & Johnson Veteran to Lead Medical Device Company on Path to Commercialization; Martin Dieck Named President and Chief Operating Officer
Nfocus Neuromedical Announces US Clearance of Unique Guiding Catheter with Uni-body Internal Skeleton
Echo™ Distal Access Guiding Catheter will provide vessel access for aneurysm treatment, stent placement and other less-invasive procedures.
Nfocus Neuromedical Obtains CE Approval for New Vascular Reconstruction Device
The CardioVasc Advantage™ Vascular Reconstruction Device now cleared for marketing in Europe.
Nfocus Neuromedical Announces European Approval for Novel Guiding Catheter at Society of NeuroInterventional Surgery
Unique uni-body construction of the Echo™ Distal Access Guiding Catheter will provide vessel access for innovative less-invasive procedures.
Nfocus Neuromedical Appoints Robert O’Holla to Head Regulator
Accomplished regulatory executive enhances Nfocus device development team.
Nfocus Neuromedical Elects Eric P. Milledge Chairman of Board
Milledge brings proven experience, dynamic insights and strategic focus to neurovascular interventions developer.
Copyright © 2012 Nfocus Neuromedical Inc. All rights reserved.